ISATIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF
申请人:Horne David A.
公开号:US20130225637A1
公开(公告)日:2013-08-29
One aspect of the invention relates to novel isatin derivative compounds and the pharmaceutical composition thereof. Another aspect of the invention relates to methods of using the isatin derivative compounds disclosed herein and the pharmaceutical compositions thereof. In certain embodiments, the method is used to treat a cancer or a tumor in a subject including, without limitation, prostate cancer, melanoma, pancreatic cancer, ovarian cancer, and lymphoma. In certain embodiment, the method is used to treat a condition in a subject that can be regulated by the activation of one or more proteins such as EGFR, Erk1/2, Her2/Neu, Jak2, Src, Stat3, Akt, Cyclin B1, and Cdc25C. In certain embodiment, the method is used to treat a condition in a subject that can be regulated by the disruption of microtubule formations.
该发明的一个方面涉及新型异喹啉衍生物化合物及其药物组合物。该发明的另一个方面涉及使用本文披露的异喹啉衍生物化合物和其药物组合物的方法。在某些实施例中,该方法用于治疗受试者中的癌症或肿瘤,包括但不限于前列腺癌、黑色素瘤、胰腺癌、卵巢癌和淋巴瘤。在某些实施例中,该方法用于治疗受试者中可以通过激活EGFR、Erk1/2、Her2/Neu、Jak2、Src、Stat3、Akt、Cyclin B1和Cdc25C等一个或多个蛋白质来调节的疾病。在某些实施例中,该方法用于治疗受试者中可以通过破坏微管形成来调节的疾病。